US20060200220A1 - Endovascular graft with sensors design and attachment methods - Google Patents

Endovascular graft with sensors design and attachment methods Download PDF

Info

Publication number
US20060200220A1
US20060200220A1 US11/417,549 US41754906A US2006200220A1 US 20060200220 A1 US20060200220 A1 US 20060200220A1 US 41754906 A US41754906 A US 41754906A US 2006200220 A1 US2006200220 A1 US 2006200220A1
Authority
US
United States
Prior art keywords
endovascular graft
sensors
graft component
attached
graft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/417,549
Inventor
Peter Brown
Mark Lemere
Kimberly Barkman
Tim Kovac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifeshield Sciences LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/417,549 priority Critical patent/US20060200220A1/en
Publication of US20060200220A1 publication Critical patent/US20060200220A1/en
Assigned to ACACIA RESEARCH GROUP LLC reassignment ACACIA RESEARCH GROUP LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ENDOVASCULAR TECHNOLOGIES, INC.
Assigned to LIFESHIELD SCIENCES LLC reassignment LIFESHIELD SCIENCES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACACIA RESEARCH GROUP LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/07Endoradiosondes
    • A61B5/076Permanent implantations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0026Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the transmission medium
    • A61B5/0028Body tissue as transmission medium, i.e. transmission systems where the medium is the human body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031Implanted circuitry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02007Evaluating blood vessel condition, e.g. elasticity, compliance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02007Evaluating blood vessel condition, e.g. elasticity, compliance
    • A61B5/02014Determining aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0204Operational features of power management
    • A61B2560/0214Operational features of power management of power generation or supply
    • A61B2560/0219Operational features of power management of power generation or supply of externally powered implanted units
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B7/00Instruments for auscultation
    • A61B7/001Detecting cranial noise, e.g. caused by aneurism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • A61F2002/067Y-shaped blood vessels modular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0001Means for transferring electromagnetic energy to implants
    • A61F2250/0002Means for transferring electromagnetic energy to implants for data transfer

Definitions

  • This invention relates to the treatment of body lumens and, more particularly, to the endovascular placement of a prosthetic graft within vasculature for the purpose of repairing the same.
  • AAA Ruptured abdominal aortic aneurysms
  • Treatment options to repair AAA include conventional open surgery and implantation of an endovascular graft.
  • Conventional open surgical repair of AAA involves major abdominal surgery with associated high rates of morbidity.
  • Endovascular grafts have been developed to endoluminally bypass abdominal aortic aneurysms through minimally invasive surgery. Many patients that are unacceptable surgical risks for open repairs are eligible for endovascular graft implantation.
  • Deployment of transfemoral, endovascular grafts to treat AAA is appealing for many reasons: avoidance of an abdominal incision, lack of aortic cross clamping, the potential for regional anesthesia, and a shortened hospital stay.
  • Untreated AAA have been shown to continue to expand until rupture, with an associated high mortality rate.
  • Implantation of endovascular grafts have also been associated with high complication rates, including perioperative death, conversion to open repair, the need for further intervention, the need for hemodialysis, a failure to cure the AAA, and wound complications.
  • Type I endoleaks are “perigraft” or “graft-related” leaks that involve a persistent channel of blood flow due to inadequate or ineffective sealing at the ends of the endovascular graft, or between overlapping components of a modular system.
  • Type II endoleaks are retrograde flow into the aneurysm sac from patent lumbar arteries, the inferior mesenteric artery, or other collateral vessels.
  • Type III endoleaks result from fabric tears, graft disconnection, or graft disintegration.
  • Type IV endoleaks are flow through the graft fabric associated with graft wall porosity or permeability. It has been recognized that preoperative patent side branches are not a good predictor of postoperative endoleaks.
  • a number of studies have focused on measurement of pressure within the aneurysm sac following implantation of an endovascular graft, both in the human patient, an animal model, or an in vitro model.
  • Properly implanted endovascular grafts have been shown to reduce the pressure within the aneurysm sac while an endoleak, with or without detectable blood flow, continues to pressurize the sac at pressures equivalent to the systemic arterial pressure.
  • Animal studies utilizing a predictable rupturing aneurysm model have shown that non-excluded aneurysms will rupture. Thrombosed aneurysm sacs may still receive pressurization from a sealed endoleak and this continued pressurization keeps the aneurysm at risk for rupture.
  • An endovascular graft with the ability to measure pressure within the aneurysm sac and provide feedback to the physician could provide acute confirmation of a procedure and identify those patients with persistent pressurization of their aneurysm, and subsequent risk of rupture.
  • an endovascular graft that facilitates non-invasive measurement of pressure, as well as other pertinent parameters, within the aneurysm sac and along the endovascular graft itself as a means for confirming the success of a procedure as well as identifying patients at risk for aneurysm rupture after the endovascular graft is implanted.
  • the measurement device increases bulk, which can significantly effect the delivery profile of the endovascular graft and increase the force necessary to deploy the device, such as jacket or release wire retraction forces. Increased bulk is a significant issue for an endovascular graft.
  • attachment of measurement devices to an endovascular graft may require sutures and the suture knots not only provide increased bulk, but are also potential graft wear points.
  • tissue growth around a measuring device attached to an implanted endovascular graft may interfere with its function and inaccurate data may result.
  • the present invention addresses these problems and other needs.
  • the present invention is embodied in an endovascular graft with sensors attached thereto.
  • the endovascular graft has the ability to be delivered endovascularly and measure pertinent parameters within the lumen in which it is implanted.
  • the endovascular graft has the ability to transmit data about intra-lumen parameters to an external monitoring device. Confirmation of a successful implant procedure is quickly and easily obtained. Patient follow-up is less costly (conducted in the physician office), non-invasive, and more accurate, allowing prompt intervention in those patients most at risk for acute AAA rupture.
  • the invention would also allow for more frequent patient follow-up, increasing the potential to diagnose and treat aneurysms at risk before acute rupture.
  • a modular endovascular graft having a main body component and one or more limb components.
  • One or more sensors are attached to the limb component(s). By attaching at least one sensor near the superior end of the limb component and sizing the main body component such that the sensor is adjacent to the aneurysm sac when the endovascular graft is implanted, measurement of pertinent parameters within the aneurysm sac is facilitated.
  • adjacent encompasses the sensor being located within the aneurysm sac or at a location where the parameters or properties being detected indicate conditions within the aneurysm sac.
  • Measurements of pertinent parameters within the aneurysm sac may allow early confirmation of a successful procedure and identification of areas of the patient's vasculature at risk for aneurysm rupture, thrombus formation, infection, inflamation or other anomalies without the need for invasive procedures.
  • An antenna or other data transmitter and a power source also may be attached to the limb component adjacent to the aneurysm sac, allowing a physician or technician to monitor graft and vessel health without the need for an invasive procedure.
  • the transmitter transmits measurements made by the sensors to a receiver located outside the patient's body. With the main body component unencumbered with sensors, transmitters or power sources, the bulk of the main body component is minimized and thereby, catheter diameter, jacket retraction and deployment complications are kept to a minimum.
  • an endovascular graft in another aspect of the invention, has attached thereto at least one integrated sensor/transmitter device capable of measuring a pertinent parameter and transmitting the measurements to an external monitoring device.
  • the integrated sensor/transmitter device has less total bulk than a sensor and independent transmitter device, thereby facilitating less total bulk for the endovascular graft.
  • the integrated sensor/transmitter device may be designed to allow one or more “satellite” sensors, having no function other than measurement, to be connected thereto.
  • a single integrated sensor/transmitter device and smaller “satellite” sensors facilitate a smaller total bulk than multiple integrated sensor/transmitter devices.
  • Attaching the integrated sensor/transmitter at a central location such as the graft crotch and “satellite” sensors at various locations on the endovascular graft facilitates measurement and transmission to an external monitoring device of pertinent parameters at multiple locations along the endovascular graft and within the lumen.
  • the “satellite” sensors allow a complete profile of pertinent parameters to be obtained and may provide more accurate identification of anomalies.
  • passive devices, or monuments which perform no sensing function may be attached to the implanted endovascular graft or directly attached to the aneurysm sac.
  • a monitoring device By tracking the location of the monuments with a monitoring device, changes in the position of the endovascular graft within the lumen or changes in the geometry of the tissue outside the endovascular graft may be detected without the problems of encapsulation or thrombus isolation associated with the measurement of pertinent parameters. Such changes may provide early detection of endovascular graft displacement or aneurysm re-dilation due to an endoleak.
  • Sensors with pressure measurement capability may be used to detect pressure changes in the aneurysm sac indicative of graft failure or endoleak due to an inadequate seal between the endovascular graft and the vasculature.
  • Sensors with temperature measurement capability may be used to detect temperature differentials associated with “hot spots” related to inflamation, infection or thrombus formation in the vessel.
  • Sensors with the capability to measure oxygen and other blood constituents such as enzymes, proteins, and nutrients, may be used to detect minute blood flow indicative of endoleak.
  • Sensors with the capability to measure electrical potential or magnetic fields may be used to detect differences in potential associated with areas of the vessel at risk for thrombus formation.
  • Sensors also may be provided to facilitate other sensing applications such as blood oxymetry, blood glucose, blood or fluid flow, biochemical or hormonal balance, blood chemistry, positional data, dynamic displacement data, ocular pressure, respiration, electro physiology, tissue stress, venous return and body acoustics.
  • sensors are attached to an endovascular graft using one continuous suture.
  • a running stitch around the sensor is used to attach the sensor to the graft fabric, thereby minimizing the number of knots necessary for attachment, in this case a single knot.
  • the running stitch may start at any location on the sensor depending on the location of the sensor on the endovascular graft. Minimizing the number of knots is advantageous because knots are potential graft wear points and add bulk.
  • a single knot attachment design may allow the sensor to be placed close to the graft crotch due to the lack of a knot at the end closest the crotch.
  • the sensors may be covered in a coating that either inhibits tissue growth or promotes a known or controlled amount and/or type of tissue growth. Because tissue growth may interfere with the ability of a sensor to perform its measurement function, inhibiting tissue growth or restricting tissue growth to a known type and/or amount may increase the reliability of measurements obtained.
  • the invention is applicable to all applications of endovascular grafts to treat aneurysmal segments of blood vessels. Furthermore, the invention and methods disclosed herein may be applied any time it is desired to measure intra-luminal parameters in a non-invasive manner. It is contemplated that the invention may be used with all shapes of endovascular grafts known within the art.
  • FIG. 1 is a partial cross-sectional view of one embodiment of the invention showing a partially assembled bifurcated endovascular graft implanted across an aneurysm sac;
  • FIG. 2 is a perspective view of another embodiment of the present invention showing a bifurcated graft with an integrated sensor/transmitter device and “satellite” sensors;
  • FIG. 4 is a partial cross-sectional view of an alternate embodiment of the invention shown in FIG. 2 showing a bifurcated graft implanted across an aneurysm sac into which an integrated sensor/transmitter device and “satellite” sensors have been attached;
  • FIG. 5 is a schematic view of another embodiment of the present invention showing an endovascular graft with monuments attached thereto implanted in a patient's body and an external source/receiver;
  • FIG. 6 is an enlarged view of a portion of graft fabric showing a sensor of the present invention attached using a single suture and running stitch.
  • the invention is embodied in a prosthetic endovascular graft having the ability to measure pertinent parameters inside the lumen into which it is implanted and transmit the measurements to a receiver located external to the patient.
  • the sensors 16 measure pertinent parameters outside the endovascular graft 10 and the power source 14 provides power for the transmitter 12 which transmits the measurements to a receiver (not shown) located outside the patient's body.
  • the transmitter 12 , power source 14 and receiver may be of any type known in the art of surgical implants or other systems utilizing miniaturized power sources and transmitters.
  • the power source 14 and transmitter 12 may be of the type used in pacemaker technology or passive power sources such as ultrasonic chargeable capacitors.
  • One or more sensors 16 are located near the superior end 32 of the limb component 30 but inferior the attachment/sealing area 26 between the trunk component 20 and limb component 30 such that the seal between the trunk component 20 and limb component 30 is not jeopardized.
  • the attachment/sealing area 26 is such that one or more of the sensors 16 on the limb component 30 is adjacent the aneurysm sac 42 , thereby facilitating measurement of pertinent parameters within the aneurysm sac 42 without encumbering the trunk component 20 with sensors 16 .
  • the transmitter 12 and power source 14 are attached to the limb component 30 such that they are also adjacent the aneurysm sac 42 . Minimizing the bulk of the trunk component facilitates a smaller delivery profile for the endovascular graft 10 .
  • the sensors 16 may measure pressure, with the measurements used as an aid in endovascular graft 10 placement or to identify anomalies that occur after endovascular graft 10 implantation but before aneurysm rupture occurs.
  • the sensors 16 may detect changes in pressure resulting from blood leakage between the endovascular graft 10 and the vessel wall 40 , an endoleak resulting from an inadequate seal between them.
  • the sensors 16 may detect changes in pressure resulting from leakage from an endoleak between the trunk 20 and vessel wall 40 .
  • the sensors 16 may measure temperature. Differences in temperature may identify “hot spots” associated with infection, inflammation, thrombus formation or other anomalies that indicate an increased risk for aneurysm rupture. Methods known in the art of pathology and physiology may be used to relate temperature to changes in the vessel walls within which the endovascular graft is implanted.
  • the sensors 16 may detect blood flow by measuring oxygen or other constituents, such as enzymes, proteins and nutrients, which are altered by the presence of blood flow. Such sensors may allow detection of minute blood flow, often missed by conventional imaging modalities, and, therefore, allow endoleaks to be detected earlier.
  • One method is to obtain a baseline of the constituents upon implantation of the endovascular graft. Thereafter, changes in the amount of the measured constituents may be used to identify anomalies.
  • the sensors 16 may measure electrical potential or magnetic field strength. Changes in electrical potential may identify areas of the patient's vasculature that are at risk for thrombus formation. Induced magnetic fields indicate motion at a charged portion of the aneurysm such as would occur from pulsatile pressure.
  • Sensors also may be provided to facilitate other sensing applications such as blood oxymetry, blood glucose, blood or fluid flow, biochemical or hormonal balance, blood chemistry, positional data, dynamic displacement data, ocular pressure, respiration, electro physiology, tissue stress, venous return and body acoustics.
  • the “satellite” sensors 52 are smaller than the integrated sensor/transmitter 50 , the overall bulk of the endovascular graft 110 is smaller than if multiple integrated sensor/transmitter devices 50 were utilized. Furthermore, the smaller “satellite” sensors 52 may be placed such that measurements may be obtained from multiple locations, such as near the superior attachment area or within the aneurysm sac 42 . Moreover, the smaller “satellite” sensors 52 facilitate measurements from places on the endovascular graft 110 where local graft bulk is a constraint of the design, such as the contra limb, or near the superior attachment system that holds the graft in the patient's aorta.
  • a separate power source 114 may be provided.
  • the power source can be integrated into the sensor/transmitter as described previously and further below.
  • the leads 54 which connect the integrated sensor/transmitter 50 to the “satellite” sensors 52 may be woven into the graft fabric or attached external to the endovascular graft 110 .
  • the location and number of integrated sensor/transmitter devices 50 , power sources 114 and “satellite” sensors 52 shown in FIG. 2 may be varied to meet the requirements of the individual patient.
  • the integrated sensor/transmitter device 50 is located at the crotch, thereby allowing it to be near the center of the aneurysm sac 42 (see FIG. 2 ) while still being located furthest away from the aneurysm wall during shrinkage.
  • the invention shown in FIG. 2 may be utilized in any type of endovascular graft implant known in the art.
  • the integrated sensor/transmitter 50 and “satellite” sensors 52 may be of any type known in the art used to measure pressure, temperature, oxygen and other blood constituents, electrical potential or any other pertinent parameter indicative of endovascular graft or lumen health.
  • One such integrated sensor/transmitter 50 to measure pressure is disclosed in U.S. Pat. Application Publication No. 2002/0045921 (Wolinsky et al.), the contents of which are hereby incorporated by reference.
  • other sensing applications may be supported such as blood oxymetry, blood glucose, blood or fluid flow, biochemical or hormonal balance, blood chemistry, positional data, dynamic displacement data, ocular pressure, respiration, electro physiology, tissue stress, venous return and body acoustics.
  • FIG. 3 shows a typical integrated sensor/transmitter 50 for use with the present invention.
  • the integrated sensor/transmitter 50 includes a control chip 55 with a transmitter/receiver, energy exchanger 56 , capacitor 57 and sensor 58 .
  • An external receiver (not shown) may contain a transducer, computer, LCD display and measurement display devices, such as barometers if the sensor 58 measures pressure.
  • the transducer in the external receiver charges the capacitor 57 using ultrasonic energy and activates the sensor 58 to measure a pertinent parameter and ultrasonically transmit the measured parameter.
  • the external receiver receives the transmitted pertinent parameter, assesses the measurement and displays the measurement, for example, as a pressure pulse curve.
  • FIG. 2 shows an integrated sensor/transmitter 50 and “satellite” sensors 52 connected by leads 54 and attached to the endovascular graft 110
  • alternate embodiments of the invention may utilize an integrated sensor/transmitter 50 as the sole implant.
  • the “satellite” sensors 52 may be attached to the vessel 40 with the integrated sensor/transmitter 50 either attached to the vessel 40 or attached to the endovascular graft 110 .
  • FIG. 4 shows an endovascular graft 110 implanted across an aneurysm sac 42 into which an integrated sensor/transmitter 50 connected to “satellite” sensors 52 by leads 54 have been attached.
  • pressure measurements in the aneurysm sac 42 may be obtained to an accuracy range of +/ ⁇ 1 to 30 mm Hg and preferably +/ ⁇ 10 mm Hg utilizing either an integrated sensor/transmitter 50 alone or in conjunction with one or more “satellite” sensors 52 or integrated sensor/transmitters 50 .
  • micro devices having the capability to sense their location relative to each other are either attached to the endovascular graft 110 or attached to the vessel 40 .
  • the micro devices may be excited by an external energy source, sense their relative location and transmit the data to a receiver located outside the patient's body. The data may then be interpreted to determine if displacement of the endovascular graft 110 or changes in the geometry of the vessel 40 has occurred. Such changes may provide early detection of endovascular graft 110 displacement or aneurysm 42 re-dilation due to an endoleak. Additional micro devices could be provided for better resolution.
  • devices or monuments which perform no sensing function may be attached to the implanted endovascular graft 110 or directly attached to the aneurysm sac 42 .
  • the location of the monuments may be tracked with a monitoring device to detect changes in the position of the endovascular graft 110 within the vessel 40 or changes in the geometry of the tissue outside the endovascular graft 110 .
  • the monitoring device may be located external the patient's body or attached to an implanted endovascular graft.
  • FIG. 5 illustrates an external monitoring device 54 being used to sense the location of an endovascular graft 310 having monuments 60 attached thereto which has been implanted in a patient's body.
  • the monuments may be electrically passive devices or magnetic sensors. The use of RF or magnets to sense the position of monuments is contemplated.
  • the position of magnetic sensors attached to the aneurysm sac 42 are measured using an external magnet of known magnetic field strength and shape. By moving the external magnet to multiple positions and orientations outside the body and polling the magnetic sensors with ultrasound, a baseline of magnetic sensor positions is established. Subsequent polling of the magnetic sensor positions allows changes in aneurysm sac 42 geometry to be detected.
  • sensors 16 or integrated sensor/transmitters 52 are attached to the endovascular graft 110 fabric using one continuous suture 70 with a running stitch, from a starting point 72 on sensor 16 , which continues around the sensor 16 and back to an end point 74 (the dashed lines in FIG. 6 indicate where the suture 70 is on the inner diameter of the endovascular graft 110 fabric).
  • Suture loops 71 are provided on the sensor 16 to facilitate attachment.
  • a single knot 75 may be used to join the ends of the suture 70 .
  • the running stitch may start and end at either end of the sensor and utilize more or less stitches depending on the location of the sensor 16 on the endovascular graft 110 and the attachment requirements.
  • Minimizing the number of knots not only reduces bulk but also reduces potential graft wear points and may allow the sensor to be placed close to the graft crotch due to the lack of a knot at the distal end. It is further contemplated that the continuous suture 70 attachment method may be utilized with sensors 16 having suture holes or any other attachment mechanism.
  • the sensors 16 may be covered in a coating, such as Teflon or heparin, to inhibit tissue growth or covered in a coating, such as Thrombin, to promote a known or controlled amount of tissue growth. Inhibiting or controlling tissue growth, which may interfere with performance, increases the reliability of the measurements made by the sensors 16 .

Abstract

A endovascular graft having sensing devices attached thereto to facilitate measurement of pertinent parameters within the vasculature into which the graft is implanted. Power sources and transmitters may be attached to the graft to facilitate transmission of measurements to a receiving device outside the patient's body. The sensing devices, may be electrically passive or integrated devices with measurement and transmission capability. The sensing devices may be attached to specific locations on the graft material or attached to the lumen, thereby providing pertinent parameters from critical points inside the vasculature, or may be dispersed over the surface of the graft material or within the lumen to provide a profile of pertinent parameters. The sensing devices may be attached to the graft material with one suture using a running stitch to minimize graft bulk and may be coated with a material to inhibit or control tissue growth.

Description

    BACKGROUND OF THE INVENTION
  • This invention relates to the treatment of body lumens and, more particularly, to the endovascular placement of a prosthetic graft within vasculature for the purpose of repairing the same.
  • Ruptured abdominal aortic aneurysms (AAA) are a leading cause of death in the United States. Treatment options to repair AAA include conventional open surgery and implantation of an endovascular graft. Conventional open surgical repair of AAA involves major abdominal surgery with associated high rates of morbidity. Endovascular grafts have been developed to endoluminally bypass abdominal aortic aneurysms through minimally invasive surgery. Many patients that are unacceptable surgical risks for open repairs are eligible for endovascular graft implantation. Deployment of transfemoral, endovascular grafts to treat AAA is appealing for many reasons: avoidance of an abdominal incision, lack of aortic cross clamping, the potential for regional anesthesia, and a shortened hospital stay.
  • Untreated AAA have been shown to continue to expand until rupture, with an associated high mortality rate. Implantation of endovascular grafts have also been associated with high complication rates, including perioperative death, conversion to open repair, the need for further intervention, the need for hemodialysis, a failure to cure the AAA, and wound complications.
  • The inability to obtain or maintain a secure seal between the vessel wall and the endovascular graft is a complication unique to endovascular aneurysm exclusion. Because the term “leak” has been associated with aneurysm rupture following conventional surgery, the term “endoleak” has been proposed as a more definitive description of this complication. It is believed that persistent endoleaks result in continued aneurysm expansion, which may eventually lead to aneurysm rupture. Aneurysms that have been successfully excluded have shown a tendency towards a reduction in aneurysm diameter. Failure to properly exclude the aneurysm from systemic arterial blood pressure keeps the patient at risk of impending rupture. Endoleaks have been classified according to the source of the leaks. Current classifications of endoleaks include four categories. Type I endoleaks are “perigraft” or “graft-related” leaks that involve a persistent channel of blood flow due to inadequate or ineffective sealing at the ends of the endovascular graft, or between overlapping components of a modular system. Type II endoleaks are retrograde flow into the aneurysm sac from patent lumbar arteries, the inferior mesenteric artery, or other collateral vessels. Type III endoleaks result from fabric tears, graft disconnection, or graft disintegration. Finally, Type IV endoleaks are flow through the graft fabric associated with graft wall porosity or permeability. It has been recognized that preoperative patent side branches are not a good predictor of postoperative endoleaks.
  • There have been a number of reported cases of aneurysm rupture following implantation of an endovascular graft. Some of the ruptures occurred in patients without a documented endoleak.
  • A number of studies have focused on measurement of pressure within the aneurysm sac following implantation of an endovascular graft, both in the human patient, an animal model, or an in vitro model. Properly implanted endovascular grafts have been shown to reduce the pressure within the aneurysm sac while an endoleak, with or without detectable blood flow, continues to pressurize the sac at pressures equivalent to the systemic arterial pressure. Animal studies utilizing a predictable rupturing aneurysm model have shown that non-excluded aneurysms will rupture. Thrombosed aneurysm sacs may still receive pressurization from a sealed endoleak and this continued pressurization keeps the aneurysm at risk for rupture.
  • Current methods of patient follow-up include arteriography, contrast-enhanced spiral computed tomography (CT), duplex ultrasonography, abdominal X-ray, and intravascular ultrasound. All of these methods are costly and involve invasive procedures with associated morbidity that may need to be performed in a hospital. None of the imaging methods are completely successful in detecting endoleaks. Therefore, the potential exists for an endoleak to go undetected until eventual rupture. An increase in aneurysm diameter is detectable, and should be considered an indication of endoleak. To avoid aneurysm rupture an increase in aneurysm diameter must be detected in a timely fashion to identify patients in need of corrective endovascular procedures.
  • An endovascular graft with the ability to measure pressure within the aneurysm sac and provide feedback to the physician could provide acute confirmation of a procedure and identify those patients with persistent pressurization of their aneurysm, and subsequent risk of rupture. Some physicians are advocating that the follow-up examinations of AAA patients focus on pressure measurements, but that this is not currently clinically feasible. Furthermore, follow-up examinations may be performed in the physician's office as opposed to a hospital. Moreover, clinicians will have a new method to study the pathology of post-endovascularly treated AAA disease.
  • Accordingly, there exists a need for an endovascular graft that facilitates non-invasive measurement of pressure, as well as other pertinent parameters, within the aneurysm sac and along the endovascular graft itself as a means for confirming the success of a procedure as well as identifying patients at risk for aneurysm rupture after the endovascular graft is implanted.
  • However, providing devices on an endovascular graft to facilitate the measurement of pertinent parameters poses problems. The measurement device increases bulk, which can significantly effect the delivery profile of the endovascular graft and increase the force necessary to deploy the device, such as jacket or release wire retraction forces. Increased bulk is a significant issue for an endovascular graft. Furthermore, attachment of measurement devices to an endovascular graft may require sutures and the suture knots not only provide increased bulk, but are also potential graft wear points. Additionally, tissue growth around a measuring device attached to an implanted endovascular graft may interfere with its function and inaccurate data may result. The present invention addresses these problems and other needs.
  • SUMMARY OF THE INVENTION
  • Briefly and in general terms, the present invention is embodied in an endovascular graft with sensors attached thereto. The endovascular graft has the ability to be delivered endovascularly and measure pertinent parameters within the lumen in which it is implanted. The endovascular graft has the ability to transmit data about intra-lumen parameters to an external monitoring device. Confirmation of a successful implant procedure is quickly and easily obtained. Patient follow-up is less costly (conducted in the physician office), non-invasive, and more accurate, allowing prompt intervention in those patients most at risk for acute AAA rupture. The invention would also allow for more frequent patient follow-up, increasing the potential to diagnose and treat aneurysms at risk before acute rupture.
  • In one aspect of the invention, a modular endovascular graft having a main body component and one or more limb components is provided. One or more sensors are attached to the limb component(s). By attaching at least one sensor near the superior end of the limb component and sizing the main body component such that the sensor is adjacent to the aneurysm sac when the endovascular graft is implanted, measurement of pertinent parameters within the aneurysm sac is facilitated. The meaning of the term “adjacent” as used herein encompasses the sensor being located within the aneurysm sac or at a location where the parameters or properties being detected indicate conditions within the aneurysm sac. Measurements of pertinent parameters within the aneurysm sac may allow early confirmation of a successful procedure and identification of areas of the patient's vasculature at risk for aneurysm rupture, thrombus formation, infection, inflamation or other anomalies without the need for invasive procedures.
  • An antenna or other data transmitter and a power source also may be attached to the limb component adjacent to the aneurysm sac, allowing a physician or technician to monitor graft and vessel health without the need for an invasive procedure. The transmitter transmits measurements made by the sensors to a receiver located outside the patient's body. With the main body component unencumbered with sensors, transmitters or power sources, the bulk of the main body component is minimized and thereby, catheter diameter, jacket retraction and deployment complications are kept to a minimum.
  • In another aspect of the invention, an endovascular graft is provided that has attached thereto at least one integrated sensor/transmitter device capable of measuring a pertinent parameter and transmitting the measurements to an external monitoring device. Although having more bulk than a sensor, the integrated sensor/transmitter device has less total bulk than a sensor and independent transmitter device, thereby facilitating less total bulk for the endovascular graft.
  • Furthermore, the integrated sensor/transmitter device may be designed to allow one or more “satellite” sensors, having no function other than measurement, to be connected thereto. A single integrated sensor/transmitter device and smaller “satellite” sensors facilitate a smaller total bulk than multiple integrated sensor/transmitter devices. Attaching the integrated sensor/transmitter at a central location such as the graft crotch and “satellite” sensors at various locations on the endovascular graft facilitates measurement and transmission to an external monitoring device of pertinent parameters at multiple locations along the endovascular graft and within the lumen. The “satellite” sensors allow a complete profile of pertinent parameters to be obtained and may provide more accurate identification of anomalies. Measurement of pertinent parameters at multiple locations along the endovascular graft or within the aneurysm sac may allow early detection of a defective seal between endovascular graft components, graft wear or changes in aneurysm geometry. The smaller “satellite” sensors may also allow pertinent parameters to be measured from locations on the endovascular graft where local graft bulk is a constraint of the design, such as the graft contra limb or near the superior attachment system that holds the graft in the patient's aorta.
  • Additionally, it is contemplated that “satellite” sensors may be attached directly to the lumen of a patient. The integrated sensor/transmitter device also may be attached directly to the lumen or attached to an implanted endovascular graft.
  • Moreover, it is contemplated that passive devices, or monuments, which perform no sensing function may be attached to the implanted endovascular graft or directly attached to the aneurysm sac. By tracking the location of the monuments with a monitoring device, changes in the position of the endovascular graft within the lumen or changes in the geometry of the tissue outside the endovascular graft may be detected without the problems of encapsulation or thrombus isolation associated with the measurement of pertinent parameters. Such changes may provide early detection of endovascular graft displacement or aneurysm re-dilation due to an endoleak.
  • Sensors with pressure measurement capability may be used to detect pressure changes in the aneurysm sac indicative of graft failure or endoleak due to an inadequate seal between the endovascular graft and the vasculature. Sensors with temperature measurement capability may be used to detect temperature differentials associated with “hot spots” related to inflamation, infection or thrombus formation in the vessel. Sensors with the capability to measure oxygen and other blood constituents such as enzymes, proteins, and nutrients, may be used to detect minute blood flow indicative of endoleak. Sensors with the capability to measure electrical potential or magnetic fields may be used to detect differences in potential associated with areas of the vessel at risk for thrombus formation. Sensors also may be provided to facilitate other sensing applications such as blood oxymetry, blood glucose, blood or fluid flow, biochemical or hormonal balance, blood chemistry, positional data, dynamic displacement data, ocular pressure, respiration, electro physiology, tissue stress, venous return and body acoustics.
  • In yet another aspect of the invention, sensors are attached to an endovascular graft using one continuous suture. Starting at one location on the sensor, a running stitch around the sensor is used to attach the sensor to the graft fabric, thereby minimizing the number of knots necessary for attachment, in this case a single knot. It is contemplated that the running stitch may start at any location on the sensor depending on the location of the sensor on the endovascular graft. Minimizing the number of knots is advantageous because knots are potential graft wear points and add bulk. Additionally, a single knot attachment design may allow the sensor to be placed close to the graft crotch due to the lack of a knot at the end closest the crotch.
  • In an additional aspect of the invention, the sensors may be covered in a coating that either inhibits tissue growth or promotes a known or controlled amount and/or type of tissue growth. Because tissue growth may interfere with the ability of a sensor to perform its measurement function, inhibiting tissue growth or restricting tissue growth to a known type and/or amount may increase the reliability of measurements obtained.
  • The invention is applicable to all applications of endovascular grafts to treat aneurysmal segments of blood vessels. Furthermore, the invention and methods disclosed herein may be applied any time it is desired to measure intra-luminal parameters in a non-invasive manner. It is contemplated that the invention may be used with all shapes of endovascular grafts known within the art.
  • Other features and advantages of the present invention will become apparent from the following detailed description taken in conjunction with the accompanying drawings, which illustrate, by way of example, the principles of the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a partial cross-sectional view of one embodiment of the invention showing a partially assembled bifurcated endovascular graft implanted across an aneurysm sac;
  • FIG. 2 is a perspective view of another embodiment of the present invention showing a bifurcated graft with an integrated sensor/transmitter device and “satellite” sensors;
  • FIG. 3 is a perspective view of a typical integrated sensor/transmitter device of the present invention;
  • FIG. 4 is a partial cross-sectional view of an alternate embodiment of the invention shown in FIG. 2 showing a bifurcated graft implanted across an aneurysm sac into which an integrated sensor/transmitter device and “satellite” sensors have been attached;
  • FIG. 5 is a schematic view of another embodiment of the present invention showing an endovascular graft with monuments attached thereto implanted in a patient's body and an external source/receiver; and
  • FIG. 6 is an enlarged view of a portion of graft fabric showing a sensor of the present invention attached using a single suture and running stitch.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • As shown in the exemplary drawings and for purposes of illustration, the invention is embodied in a prosthetic endovascular graft having the ability to measure pertinent parameters inside the lumen into which it is implanted and transmit the measurements to a receiver located external to the patient.
  • Referring to FIG. 1, an embodiment of the invention is shown in which a modular bifurcated endovascular graft 10 of the type known within the art is implanted in a body vessel 40 across an aneurysm sac 42 in the area of the contra-lateral 44 and ipsi-lateral 46 iliac arteries using methods known within the art (only the contra-lateral limb is shown). The bifurcated endovascular graft 10 may be assembled in-vivo from a tubular trunk component 20 and two limb components 30. The trunk component 20 has a superior end 22 adapted to be secured above the aneurysm and an inferior end 24 adapted to accept the limb components 30. The limb component 30 has a transmitter 12, power source 14, and sensors 16 attached external the graft material. The transmitter 12, power source 14 and sensors 16 can be integrated into one device as described below. The limb component 30 has a superior end 32 adapted to mate with the trunk component 20 inferior end 24 and an inferior end 34 adapted to be secured to the ipsi-lateral 44 iliac artery.
  • The sensors 16 measure pertinent parameters outside the endovascular graft 10 and the power source 14 provides power for the transmitter 12 which transmits the measurements to a receiver (not shown) located outside the patient's body. The transmitter 12, power source 14 and receiver (not shown) may be of any type known in the art of surgical implants or other systems utilizing miniaturized power sources and transmitters. The power source 14 and transmitter 12, for example, may be of the type used in pacemaker technology or passive power sources such as ultrasonic chargeable capacitors.
  • One or more sensors 16 are located near the superior end 32 of the limb component 30 but inferior the attachment/sealing area 26 between the trunk component 20 and limb component 30 such that the seal between the trunk component 20 and limb component 30 is not jeopardized. Note that the attachment/sealing area 26 is such that one or more of the sensors 16 on the limb component 30 is adjacent the aneurysm sac 42, thereby facilitating measurement of pertinent parameters within the aneurysm sac 42 without encumbering the trunk component 20 with sensors 16. Note also that the transmitter 12 and power source 14 are attached to the limb component 30 such that they are also adjacent the aneurysm sac 42. Minimizing the bulk of the trunk component facilitates a smaller delivery profile for the endovascular graft 10.
  • The sensors 16 may measure pressure, with the measurements used as an aid in endovascular graft 10 placement or to identify anomalies that occur after endovascular graft 10 implantation but before aneurysm rupture occurs. The sensors 16 may detect changes in pressure resulting from blood leakage between the endovascular graft 10 and the vessel wall 40, an endoleak resulting from an inadequate seal between them. Furthermore, the sensors 16 may detect changes in pressure resulting from leakage from an endoleak between the trunk 20 and vessel wall 40. Because sensors 16 are located in the area of the aneurysm sac 42, there may be multiple sensors 16 disbursed over the graft material outer wall since local thrombus or calcification may shield one or more of the sensors 16 from blood flow and render their measurements erroneous. Moreover, the sensors 16 may allow pressure differences throughout the “excluded” aneurysm sac 42 to be mapped. It is contemplated that pressure measurements in the aneurysm sac may be obtained to an accuracy range of +/−1 to 30 mm Hg and preferably of +/−10 mm Hg.
  • Alternatively, the sensors 16 may measure temperature. Differences in temperature may identify “hot spots” associated with infection, inflammation, thrombus formation or other anomalies that indicate an increased risk for aneurysm rupture. Methods known in the art of pathology and physiology may be used to relate temperature to changes in the vessel walls within which the endovascular graft is implanted.
  • Alternatively, the sensors 16 may detect blood flow by measuring oxygen or other constituents, such as enzymes, proteins and nutrients, which are altered by the presence of blood flow. Such sensors may allow detection of minute blood flow, often missed by conventional imaging modalities, and, therefore, allow endoleaks to be detected earlier. One method is to obtain a baseline of the constituents upon implantation of the endovascular graft. Thereafter, changes in the amount of the measured constituents may be used to identify anomalies.
  • Alternatively, the sensors 16 may measure electrical potential or magnetic field strength. Changes in electrical potential may identify areas of the patient's vasculature that are at risk for thrombus formation. Induced magnetic fields indicate motion at a charged portion of the aneurysm such as would occur from pulsatile pressure.
  • Sensors also may be provided to facilitate other sensing applications such as blood oxymetry, blood glucose, blood or fluid flow, biochemical or hormonal balance, blood chemistry, positional data, dynamic displacement data, ocular pressure, respiration, electro physiology, tissue stress, venous return and body acoustics.
  • Although shown external the limb component 30 in FIG. 1, it is contemplated that the transmitter 12, power source 14 and sensors 16 may be located internal the graft material of the limb component 30. It is further contemplated that the number of transmitters 12, power sources 14 and sensors 16 shown in FIG. 1 may be varied to meet the requirements of the individual patient. It is further contemplated that sensors 16 which measure different pertinent parameters may be used together. Moreover, the invention shown in FIG. 1 may be utilized in any type of endovascular graft implant known in the art.
  • Referring to FIG. 2, another embodiment of the invention is shown in which an integrated sensor/transmitter 50 is attached to the endovascular graft 110 and “satellite” sensors 52 are attached at various locations on the endovascular graft 110. The integrated sensor/transmitter 50 is capable of measuring a pertinent parameter as well as transmitting measurements to a receiver (not shown) outside that patient's body. The “satellite” sensors 52 only measure pertinent parameters and their measurements are transmitted by the integrated sensor/transmitter, to which they are connected by leads 54. The “satellite” sensors 52 may provide a complete profile of pertinent parameters over the surface of the endovascular graft 110 and, therefore, facilitate better identification of anomalies.
  • Because the “satellite” sensors 52 are smaller than the integrated sensor/transmitter 50, the overall bulk of the endovascular graft 110 is smaller than if multiple integrated sensor/transmitter devices 50 were utilized. Furthermore, the smaller “satellite” sensors 52 may be placed such that measurements may be obtained from multiple locations, such as near the superior attachment area or within the aneurysm sac 42. Moreover, the smaller “satellite” sensors 52 facilitate measurements from places on the endovascular graft 110 where local graft bulk is a constraint of the design, such as the contra limb, or near the superior attachment system that holds the graft in the patient's aorta.
  • A separate power source 114 may be provided. The power source can be integrated into the sensor/transmitter as described previously and further below. The leads 54 which connect the integrated sensor/transmitter 50 to the “satellite” sensors 52 may be woven into the graft fabric or attached external to the endovascular graft 110.
  • It is contemplated that the location and number of integrated sensor/transmitter devices 50, power sources 114 and “satellite” sensors 52 shown in FIG. 2 may be varied to meet the requirements of the individual patient. In the embodiment shown, the integrated sensor/transmitter device 50 is located at the crotch, thereby allowing it to be near the center of the aneurysm sac 42 (see FIG. 2) while still being located furthest away from the aneurysm wall during shrinkage. It is further contemplated that the invention shown in FIG. 2 may be utilized in any type of endovascular graft implant known in the art.
  • Moreover, the integrated sensor/transmitter 50 and “satellite” sensors 52 may be of any type known in the art used to measure pressure, temperature, oxygen and other blood constituents, electrical potential or any other pertinent parameter indicative of endovascular graft or lumen health. One such integrated sensor/transmitter 50 to measure pressure is disclosed in U.S. Pat. Application Publication No. 2002/0045921 (Wolinsky et al.), the contents of which are hereby incorporated by reference. Again, other sensing applications may be supported such as blood oxymetry, blood glucose, blood or fluid flow, biochemical or hormonal balance, blood chemistry, positional data, dynamic displacement data, ocular pressure, respiration, electro physiology, tissue stress, venous return and body acoustics.
  • FIG. 3 shows a typical integrated sensor/transmitter 50 for use with the present invention. The integrated sensor/transmitter 50 includes a control chip 55 with a transmitter/receiver, energy exchanger 56, capacitor 57 and sensor 58. An external receiver (not shown) may contain a transducer, computer, LCD display and measurement display devices, such as barometers if the sensor 58 measures pressure. In operation, the transducer in the external receiver charges the capacitor 57 using ultrasonic energy and activates the sensor 58 to measure a pertinent parameter and ultrasonically transmit the measured parameter. The external receiver receives the transmitted pertinent parameter, assesses the measurement and displays the measurement, for example, as a pressure pulse curve.
  • Although FIG. 2 shows an integrated sensor/transmitter 50 and “satellite” sensors 52 connected by leads 54 and attached to the endovascular graft 110, alternate embodiments of the invention may utilize an integrated sensor/transmitter 50 as the sole implant. Furthermore, the “satellite” sensors 52 may be attached to the vessel 40 with the integrated sensor/transmitter 50 either attached to the vessel 40 or attached to the endovascular graft 110. FIG. 4 shows an endovascular graft 110 implanted across an aneurysm sac 42 into which an integrated sensor/transmitter 50 connected to “satellite” sensors 52 by leads 54 have been attached. It is contemplated that pressure measurements in the aneurysm sac 42 may be obtained to an accuracy range of +/−1 to 30 mm Hg and preferably +/−10 mm Hg utilizing either an integrated sensor/transmitter 50 alone or in conjunction with one or more “satellite” sensors 52 or integrated sensor/transmitters 50.
  • In an alternate embodiment of the invention illustrated in FIGS. 2 and 4, micro devices having the capability to sense their location relative to each other are either attached to the endovascular graft 110 or attached to the vessel 40. The micro devices may be excited by an external energy source, sense their relative location and transmit the data to a receiver located outside the patient's body. The data may then be interpreted to determine if displacement of the endovascular graft 110 or changes in the geometry of the vessel 40 has occurred. Such changes may provide early detection of endovascular graft 110 displacement or aneurysm 42 re-dilation due to an endoleak. Additional micro devices could be provided for better resolution. Detecting location of the micro devices rather than measuring a pertinent parameter minimizes reliability problems due to encapsulation or thrombus isolation. It is contemplated that the micro devices may be an ultrasonic crystal attached or integral to a MEM chip having the ability to read, interpret and transmit data. The micro devices also may be ultrasonic or other energy reflectors utilized in conjunction with an energy source. Using ultrasound to show or image reflector location would be much easier than creating an ultrasound image of the tissue.
  • In a further embodiment of the invention illustrated in FIGS. 2 and 4, devices or monuments which perform no sensing function may be attached to the implanted endovascular graft 110 or directly attached to the aneurysm sac 42. The location of the monuments may be tracked with a monitoring device to detect changes in the position of the endovascular graft 110 within the vessel 40 or changes in the geometry of the tissue outside the endovascular graft 110. It is contemplated that the monitoring device may be located external the patient's body or attached to an implanted endovascular graft. FIG. 5 illustrates an external monitoring device 54 being used to sense the location of an endovascular graft 310 having monuments 60 attached thereto which has been implanted in a patient's body. It is contemplated that the monuments may be electrically passive devices or magnetic sensors. The use of RF or magnets to sense the position of monuments is contemplated.
  • In one example, the position of magnetic sensors attached to the aneurysm sac 42 are measured using an external magnet of known magnetic field strength and shape. By moving the external magnet to multiple positions and orientations outside the body and polling the magnetic sensors with ultrasound, a baseline of magnetic sensor positions is established. Subsequent polling of the magnetic sensor positions allows changes in aneurysm sac 42 geometry to be detected.
  • In yet another embodiment of the invention shown in FIG. 6, sensors 16 or integrated sensor/transmitters 52 are attached to the endovascular graft 110 fabric using one continuous suture 70 with a running stitch, from a starting point 72 on sensor 16, which continues around the sensor 16 and back to an end point 74 (the dashed lines in FIG. 6 indicate where the suture 70 is on the inner diameter of the endovascular graft 110 fabric). Suture loops 71 are provided on the sensor 16 to facilitate attachment. A single knot 75 may be used to join the ends of the suture 70. It is contemplated that the running stitch may start and end at either end of the sensor and utilize more or less stitches depending on the location of the sensor 16 on the endovascular graft 110 and the attachment requirements. Minimizing the number of knots not only reduces bulk but also reduces potential graft wear points and may allow the sensor to be placed close to the graft crotch due to the lack of a knot at the distal end. It is further contemplated that the continuous suture 70 attachment method may be utilized with sensors 16 having suture holes or any other attachment mechanism.
  • In yet another embodiment of the invention, the sensors 16 may be covered in a coating, such as Teflon or heparin, to inhibit tissue growth or covered in a coating, such as Thrombin, to promote a known or controlled amount of tissue growth. Inhibiting or controlling tissue growth, which may interfere with performance, increases the reliability of the measurements made by the sensors 16.
  • While several particular forms of the invention have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.

Claims (20)

1-21. (canceled)
22. A modular endoluminal prosthesis for repairing an aneurysm in vasculature, comprising:
a first endovascular graft component; and
a second endovascular graft component for attachment to the first endovascular graft component, the second endovascular graft component having one or more sensors attached thereto and wherein at least one sensor is located on the external surface of the second endovascular graft component.
23. The prosthesis of claim 22, further comprising:
one or more power sources attached to the second endovascular graft component; and
one or more transmitting devices attached to the second endovascular graft component, each transmitting device capable of transmitting signals containing the parameters measured by one or more sensors to a location outside a patient's body.
24. The prosthesis of claim 23, wherein one or more of the power sources are located on the external surface of the second endovascular graft component.
25. The prosthesis of claim 23, wherein one or more of the transmitting devices are located on the external surface of the second endovascular graft component.
26. The prosthesis of claim 22, further comprising one or more receiving devices located outside a patient's body, each receiving device capable of receiving signals transmitted by one or more transmitters.
27. The prosthesis of claim 22, wherein one of the first and second endovascular graft components is generally tubular and each has a superior end, an inferior end and a midsection.
28. The prosthesis of claim 27, wherein one or more sensors are located on the second endovascular graft component at a midsection thereof.
29. The prosthesis of claim 22, wherein the first endovascular graft component has a trunk portion and at least one limb portion.
30-75. (canceled)
76. A method of measuring pertinent parameters in the vasculature of a patient, comprising:
providing one or more sensors in the vasculature, each sensor capable of measuring a pertinent parameter and transmitting the measurement to a receiving device;
providing a receiving/transmitting device capable of receiving measurements from the sensors and transmitting the measurements to a receiving device outside the patient's body; and
providing one or more receiving devices outside the patient's body, each receiving device capable of receiving the measurements transmitted by the receiving/transmitting device.
77. The method of claim 76, wherein the sensors are attached to an endoluminal prosthesis implanted in the vasculature.
78. The method of claim 76, wherein the sensors are attached to a lumen wall of the vasculature.
79. The method of claim 77, the endoluminal prosthesis further comprising a first endovascular graft component and a second endovascular graft component for attachment to the first endovascular graft component, the second endovascular graft component having one or more sensors attached thereto and wherein at least one sensor is adjacent an aneurysm when the first and second endovascular graft components are implanted within the vasculature.
80. The method of claim 77, the endoluminal prosthesis further comprising a first endovascular graft component and a second endovascular graft component for attachment to the first endovascular graft component, the second endovascular graft component having one or more sensors attached thereto and wherein at least one sensor is located on the external surface of the second endovascular graft component.
81. The method of claim 77, the endoluminal prosthesis further comprising at least one integrated sensor/transmitter device capable of measuring and transmitting a pertinent parameter to the receiving device.
82. The method of claim 81, wherein the integrated sensor/transmitter device is connected to one or more sensors by electrical leads and wherein the integrated sensor/transmitter device is capable of sensing the parameter measured by each sensor and transmitting the parameter to the receiving device.
83. The method of claim 76, wherein the receiving/transmitting device is attached to a lumen wall of the vasculature.
84. The method of claim 76, wherein the receiving/transmitting device is attached to an endovascular graft implanted in the vasculature.
85-106. (canceled)
US11/417,549 2002-06-07 2006-05-04 Endovascular graft with sensors design and attachment methods Abandoned US20060200220A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/417,549 US20060200220A1 (en) 2002-06-07 2006-05-04 Endovascular graft with sensors design and attachment methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/165,763 US7261733B1 (en) 2002-06-07 2002-06-07 Endovascular graft with sensors design and attachment methods
US11/417,549 US20060200220A1 (en) 2002-06-07 2006-05-04 Endovascular graft with sensors design and attachment methods

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/165,763 Continuation US7261733B1 (en) 2002-06-07 2002-06-07 Endovascular graft with sensors design and attachment methods

Publications (1)

Publication Number Publication Date
US20060200220A1 true US20060200220A1 (en) 2006-09-07

Family

ID=29732090

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/165,763 Expired - Fee Related US7261733B1 (en) 2002-06-07 2002-06-07 Endovascular graft with sensors design and attachment methods
US11/417,549 Abandoned US20060200220A1 (en) 2002-06-07 2006-05-04 Endovascular graft with sensors design and attachment methods

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/165,763 Expired - Fee Related US7261733B1 (en) 2002-06-07 2002-06-07 Endovascular graft with sensors design and attachment methods

Country Status (3)

Country Link
US (2) US7261733B1 (en)
EP (1) EP1511443B1 (en)
WO (1) WO2003103539A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060265043A1 (en) * 2002-09-30 2006-11-23 Evgenia Mandrusov Method and apparatus for treating vulnerable plaque
US20080125851A1 (en) * 2002-09-30 2008-05-29 Deborah Kilpatrick Method and apparatus for treating vulnerable plaque
US20090247887A1 (en) * 2008-03-28 2009-10-01 David Hull Flow measurement in grafts
US8165663B2 (en) 2007-10-03 2012-04-24 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation
US8285366B2 (en) 2007-10-04 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a local bypass
US8285367B2 (en) 2007-10-05 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a reservoir
US8602983B2 (en) 2010-12-20 2013-12-10 Covidien Lp Access assembly having undercut structure
US8641610B2 (en) 2010-12-20 2014-02-04 Covidien Lp Access assembly with translating lumens
US8696557B2 (en) 2010-12-21 2014-04-15 Covidien Lp Access assembly including inflatable seal member
US9314584B1 (en) 2011-06-27 2016-04-19 Bayer Healthcare Llc Method and apparatus for fractional flow reserve measurements
US20160220125A1 (en) * 2015-01-30 2016-08-04 Infineon Technologies Ag Implantable Vessel Fluid Sensor
US9649113B2 (en) 2011-04-27 2017-05-16 Covidien Lp Device for monitoring physiological parameters in vivo
US9757591B2 (en) 2013-02-11 2017-09-12 Bayer Healthcare Llc Methods and systems for monitoring an automated infusion system
US10420583B2 (en) 2013-05-22 2019-09-24 Covidien Lp Methods and apparatus for controlling surgical instruments using a port assembly
US11883028B2 (en) 2021-09-08 2024-01-30 Covidien Lp Systems and methods for post-operative anastomotic leak detection

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034100B2 (en) 1999-03-11 2011-10-11 Endologix, Inc. Graft deployment system
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
US7488345B2 (en) * 2002-06-07 2009-02-10 Endovascular Technologies, Inc. Endovascular graft with pressor and attachment methods
US7399313B2 (en) * 2002-06-07 2008-07-15 Brown Peter S Endovascular graft with separable sensors
US7261733B1 (en) 2002-06-07 2007-08-28 Endovascular Technologies, Inc. Endovascular graft with sensors design and attachment methods
DE102004023526A1 (en) * 2004-05-13 2005-12-08 Osypka, Peter, Dr.-Ing. Container support for closing blood vessels within patient has at least one measuring instrument for detecting medical characteristic
US7918800B1 (en) * 2004-10-08 2011-04-05 Endovascular Technologies, Inc. Aneurysm sensing devices and delivery systems
US7963989B2 (en) 2005-01-24 2011-06-21 Technology Advancement Group, Inc. Implantable prosthetic device for connection to a fluid flow pathway of a patient
US20070225797A1 (en) * 2006-03-24 2007-09-27 Medtronic Vascular, Inc. Prosthesis With Adjustable Opening for Side Branch Access
EP2037999B1 (en) 2006-07-07 2016-12-28 Proteus Digital Health, Inc. Smart parenteral administration system
US20080058772A1 (en) * 2006-08-31 2008-03-06 Robertson Timothy L Personal paramedic
US8523931B2 (en) 2007-01-12 2013-09-03 Endologix, Inc. Dual concentric guidewire and methods of bifurcated graft deployment
US7677107B2 (en) * 2007-07-03 2010-03-16 Endotronix, Inc. Wireless pressure sensor and method for fabricating wireless pressure sensor for integration with an implantable device
EP2211974A4 (en) 2007-10-25 2013-02-27 Proteus Digital Health Inc Fluid transfer port information system
WO2009067463A1 (en) 2007-11-19 2009-05-28 Proteus Biomedical, Inc. Body-associated fluid transport structure evaluation devices
WO2009105699A1 (en) 2008-02-22 2009-08-27 Endologix, Inc. Design and method of placement of a graft or graft system
WO2009114678A1 (en) * 2008-03-13 2009-09-17 Carolon Company Health monitoring and management system
US8236040B2 (en) 2008-04-11 2012-08-07 Endologix, Inc. Bifurcated graft deployment systems and methods
EP2520320B1 (en) 2008-07-01 2016-11-02 Endologix, Inc. Catheter system
EP2429452B1 (en) 2009-04-28 2020-01-15 Endologix, Inc. Endoluminal prosthesis system
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
US9579103B2 (en) 2009-05-01 2017-02-28 Endologix, Inc. Percutaneous method and device to treat dissections
WO2011008989A2 (en) 2009-07-15 2011-01-20 Endologix, Inc. Stent graft
US8118856B2 (en) 2009-07-27 2012-02-21 Endologix, Inc. Stent graft
WO2011064782A2 (en) 2009-11-30 2011-06-03 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
SG182825A1 (en) 2010-02-01 2012-09-27 Proteus Biomedical Inc Data gathering system
EP2531096A4 (en) 2010-02-01 2013-09-11 Proteus Digital Health Inc Two-wrist data gathering system
CA2789304C (en) * 2010-02-08 2018-01-02 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
EP2635241B1 (en) 2010-11-02 2019-02-20 Endologix, Inc. Apparatus for placement of a graft or graft system
WO2012068298A1 (en) 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
US9526638B2 (en) 2011-02-03 2016-12-27 Endospan Ltd. Implantable medical devices constructed of shape memory material
CN105232195B (en) 2011-03-01 2018-06-08 恩朵罗杰克斯股份有限公司 Delivery catheter system
WO2012117395A1 (en) 2011-03-02 2012-09-07 Endospan Ltd. Reduced-strain extra- vascular ring for treating aortic aneurysm
EP2709520A4 (en) * 2011-05-17 2014-12-10 Landy Aaron Toth Devices, systems, and methods for assessing implants, organs, transplants, tissues, synthetic constructs, vascular grafts, and the like
US9254209B2 (en) 2011-07-07 2016-02-09 Endospan Ltd. Stent fixation with reduced plastic deformation
WO2013030818A2 (en) 2011-08-28 2013-03-07 Endospan Ltd. Stent-grafts with post-deployment variable axial and radial displacement
US9427339B2 (en) 2011-10-30 2016-08-30 Endospan Ltd. Triple-collar stent-graft
US9993360B2 (en) 2013-01-08 2018-06-12 Endospan Ltd. Minimization of stent-graft migration during implantation
EP2948049A4 (en) 2013-01-24 2016-10-19 Graftworx Llc Method and apparatus for measuring flow through a lumen
US9668892B2 (en) 2013-03-11 2017-06-06 Endospan Ltd. Multi-component stent-graft system for aortic dissections
US10603197B2 (en) 2013-11-19 2020-03-31 Endospan Ltd. Stent system with radial-expansion locking
WO2016028585A1 (en) 2014-08-18 2016-02-25 St. Jude Medical, Cardiology Division, Inc. Sensors for prosthetic heart devices
US10433791B2 (en) 2014-08-18 2019-10-08 St. Jude Medical, Cardiology Division, Inc. Prosthetic heart devices having diagnostic capabilities
WO2016028583A1 (en) 2014-08-18 2016-02-25 St. Jude Medical, Cardiology Division, Inc. Sensors for prosthetic heart devices
BR112017012425A2 (en) 2014-12-18 2018-01-02 Endospan Ltd endovascular stent graft with fatigue resistant lateral tube
US9924905B2 (en) 2015-03-09 2018-03-27 Graftworx, Inc. Sensor position on a prosthesis for detection of a stenosis
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
WO2017072695A1 (en) * 2015-10-28 2017-05-04 Jayandiran Pillai Aneurysm occluder
WO2018049412A1 (en) 2016-09-12 2018-03-15 Graftworx, Inc. Wearable device with multimodal diagnostics
EP3585252A1 (en) 2017-02-24 2020-01-01 Endotronix, Inc. Wireless sensor reader assembly
US11615257B2 (en) 2017-02-24 2023-03-28 Endotronix, Inc. Method for communicating with implant devices
CA3133857A1 (en) 2019-03-20 2020-09-24 inQB8 Medical Technologies, LLC Aortic dissection implant

Citations (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2634721A (en) * 1951-05-19 1953-04-14 Gen Precision Lab Inc Pressure transducer
US3240207A (en) * 1963-05-31 1966-03-15 North American Aviation Inc Pressure sensor
US3888708A (en) * 1972-02-17 1975-06-10 Kensall D Wise Method for forming regions of predetermined thickness in silicon
US4732874A (en) * 1986-10-15 1988-03-22 Delco Electronics Corporation Removing metal precipitates from semiconductor devices
US4815472A (en) * 1987-06-01 1989-03-28 The Regents Of The University Of Michigan Multipoint pressure-sensing catheter system
US4834101A (en) * 1987-06-26 1989-05-30 The University Of Michigan Catheter-type electrochemical sensors
US4846191A (en) * 1988-05-27 1989-07-11 Data Sciences, Inc. Device for chronic measurement of internal body pressure
US4881410A (en) * 1987-06-01 1989-11-21 The Regents Of The University Of Michigan Ultraminiature pressure sensor and method of making same
US4946562A (en) * 1987-01-29 1990-08-07 Medtest Systems, Inc. Apparatus and methods for sensing fluid components
US4953387A (en) * 1989-07-31 1990-09-04 The Regents Of The University Of Michigan Ultrathin-film gas detector
US5000049A (en) * 1988-08-02 1991-03-19 Cooper Robert P Pressure gauge for medical applications
US5013396A (en) * 1987-06-01 1991-05-07 The Regents Of The University Of Michigan Method of making an ultraminiature pressure sensor
US5055838A (en) * 1988-12-09 1991-10-08 The Regents Of The University Of Michigan Silicon tactile imaging array and method of making same
US5059543A (en) * 1990-09-21 1991-10-22 The Board Of Regents Acting For And On Behalf Of The University Of Michigan Method of manufacturing thermopile infrared detector
US5100479A (en) * 1990-09-21 1992-03-31 The Board Of Regents Acting For And On Behalf Of The University Of Michigan Thermopile infrared detector with semiconductor supporting rim
US5113868A (en) * 1987-06-01 1992-05-19 The Regents Of The University Of Michigan Ultraminiature pressure sensor with addressable read-out circuit
US5165407A (en) * 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor
US5207103A (en) * 1987-06-01 1993-05-04 Wise Kensall D Ultraminiature single-crystal sensor with movable member
US5213999A (en) * 1990-09-04 1993-05-25 Delco Electronics Corporation Method of metal filled trench buried contacts
US5250461A (en) * 1991-05-17 1993-10-05 Delco Electronics Corporation Method for dielectrically isolating integrated circuits using doped oxide sidewalls
US5250837A (en) * 1991-05-17 1993-10-05 Delco Electronics Corporation Method for dielectrically isolating integrated circuits using doped oxide sidewalls
US5262127A (en) * 1992-02-12 1993-11-16 The Regents Of The University Of Michigan Solid state chemical micro-reservoirs
US5296255A (en) * 1992-02-14 1994-03-22 The Regents Of The University Of Michigan In-situ monitoring, and growth of thin films by means of selected area CVD
US5314458A (en) * 1990-06-01 1994-05-24 University Of Michigan Single channel microstimulator
US5343064A (en) * 1988-03-18 1994-08-30 Spangler Leland J Fully integrated single-crystal silicon-on-insulator process, sensors and circuits
US5377524A (en) * 1992-06-22 1995-01-03 The Regents Of The University Of Michigan Self-testing capacitive pressure transducer and method
US5411551A (en) * 1992-08-05 1995-05-02 Ultrasonic Sensing And Monitoring Systems, Inc. Stent assembly with sensor
US5417235A (en) * 1993-07-28 1995-05-23 Regents Of The University Of Michigan Integrated microvalve structures with monolithic microflow controller
US5427975A (en) * 1993-05-10 1995-06-27 Delco Electronics Corporation Method of micromachining an integrated sensor on the surface of a silicon wafer
US5547093A (en) * 1994-09-14 1996-08-20 Delco Electronics Corporation Method for forming a micromachine motion sensor
US5567989A (en) * 1993-07-27 1996-10-22 Samsung Electronics Co., Ltd. Highly integrated semiconductor wiring structure
US5598847A (en) * 1994-12-28 1997-02-04 Pacesetter, Inc. Implantable flow sensor apparatus and method
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5653743A (en) * 1994-09-09 1997-08-05 Martin; Eric C. Hypogastric artery bifurcation graft and method of implantation
US5663508A (en) * 1995-08-07 1997-09-02 Delco Electronics Corporation Silicon flow sensor
US5676696A (en) * 1995-02-24 1997-10-14 Intervascular, Inc. Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5704352A (en) * 1995-11-22 1998-01-06 Tremblay; Gerald F. Implantable passive bio-sensor
US5706565A (en) * 1996-09-03 1998-01-13 Delco Electronics Corporation Method for making an all-silicon capacitive pressure sensor
US5719069A (en) * 1994-09-14 1998-02-17 Delco Electronics Corporation One-chip integrated sensor process
US5735887A (en) * 1996-12-10 1998-04-07 Exonix Corporation Closed-loop, RF-coupled implanted medical device
US5756900A (en) * 1993-12-28 1998-05-26 Tasco Japan Co., Ltd. Pressure sensing apparatus
US5807258A (en) * 1997-10-14 1998-09-15 Cimochowski; George E. Ultrasonic sensors for monitoring the condition of a vascular graft
US5831162A (en) * 1997-01-21 1998-11-03 Delco Electronics Corporation Silicon micromachined motion sensor and method of making
US5915281A (en) * 1997-10-03 1999-06-22 Delco Electronics Corporation Silicon force and displacement sensor
US5929497A (en) * 1998-06-11 1999-07-27 Delco Electronics Corporation Batch processed multi-lead vacuum packaging for integrated sensors and circuits
US5932809A (en) * 1998-02-17 1999-08-03 Delco Electronics Corporation Sensor with silicon strain gage
US5936164A (en) * 1997-08-27 1999-08-10 Delco Electronics Corporation All-silicon capacitive pressure sensor
US5967986A (en) * 1997-11-25 1999-10-19 Vascusense, Inc. Endoluminal implant with fluid flow sensing capability
US5976994A (en) * 1997-06-13 1999-11-02 Regents Of The University Of Michigan Method and system for locally annealing a microstructure formed on a substrate and device formed thereby
US5989445A (en) * 1995-06-09 1999-11-23 The Regents Of The University Of Michigan Microchannel system for fluid delivery
US6015387A (en) * 1997-03-20 2000-01-18 Medivas, Llc Implantation devices for monitoring and regulating blood flow
US6022756A (en) * 1998-07-31 2000-02-08 Delco Electronics Corp. Metal diaphragm sensor with polysilicon sensing elements and methods therefor
US6035714A (en) * 1997-09-08 2000-03-14 The Regents Of The University Of Michigan Microelectromechanical capacitive accelerometer and method of making same
US6053873A (en) * 1997-01-03 2000-04-25 Biosense, Inc. Pressure-sensing stent
US6062461A (en) * 1998-06-03 2000-05-16 Delphi Technologies, Inc. Process for bonding micromachined wafers using solder
US6077298A (en) * 1999-02-20 2000-06-20 Tu; Lily Chen Expandable/retractable stent and methods thereof
US6092530A (en) * 1999-03-24 2000-07-25 The B.F. Goodrich Company Remotely interrogated implant device with sensor for detecting accretion of biological matter
US6109113A (en) * 1998-06-11 2000-08-29 Delco Electronics Corp. Silicon micromachined capacitive pressure sensor and method of manufacture
US6136212A (en) * 1996-08-12 2000-10-24 The Regents Of The University Of Michigan Polymer-based micromachining for microfluidic devices
US6140144A (en) * 1996-08-08 2000-10-31 Integrated Sensing Systems, Inc. Method for packaging microsensors
US6140740A (en) * 1997-12-30 2000-10-31 Remon Medical Technologies, Ltd. Piezoelectric transducer
US6159156A (en) * 1997-08-15 2000-12-12 Rijksuniversiteit Leiden Pressure sensor for use in an artery
US6167757B1 (en) * 1997-09-08 2001-01-02 The Regents Of The University Of Michigan Single-side microelectromechanical capacitive accelerometer and method of making same
US6171253B1 (en) * 1999-05-04 2001-01-09 Apex Medical, Inc. Flat tube pressure sensor
US6170488B1 (en) * 1999-03-24 2001-01-09 The B. F. Goodrich Company Acoustic-based remotely interrogated diagnostic implant device and system
US6198965B1 (en) * 1997-12-30 2001-03-06 Remon Medical Technologies, Ltd. Acoustic telemetry system and method for monitoring a rejection reaction of a transplanted organ
US6206835B1 (en) * 1999-03-24 2001-03-27 The B. F. Goodrich Company Remotely interrogated diagnostic implant device with electrically passive sensor
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6231516B1 (en) * 1997-10-14 2001-05-15 Vacusense, Inc. Endoluminal implant with therapeutic and diagnostic capability
US6232150B1 (en) * 1998-12-03 2001-05-15 The Regents Of The University Of Michigan Process for making microstructures and microstructures made thereby
US6239724B1 (en) * 1997-12-30 2001-05-29 Remon Medical Technologies, Ltd. System and method for telemetrically providing intrabody spatial position
US6237398B1 (en) * 1997-12-30 2001-05-29 Remon Medical Technologies, Ltd. System and method for monitoring pressure, flow and constriction parameters of plumbing and blood vessels
US20010026111A1 (en) * 1997-12-30 2001-10-04 Remon Medical Technologies Ltd. Acoustic biosensor for monitoring physiological conditions in a body implantation site
US6300632B1 (en) * 1999-10-14 2001-10-09 The Regents Of The University Of Michigan Uncooled infrared focal plane imager and microelectromechanical infrared detector for use therein
US6416474B1 (en) * 2000-03-10 2002-07-09 Ramon Medical Technologies Ltd. Systems and methods for deploying a biosensor in conjunction with a prosthesis
US6442413B1 (en) * 2000-05-15 2002-08-27 James H. Silver Implantable sensor
US20020147405A1 (en) * 2001-04-05 2002-10-10 Stephen Denker Cardiac monitoring system and method with multiple implanted transponders
US6475170B1 (en) * 1997-12-30 2002-11-05 Remon Medical Technologies Ltd Acoustic biosensor for monitoring physiological conditions in a body implantation site
US6477426B1 (en) * 2000-06-20 2002-11-05 Celsion Corporation System and method for heating the prostate gland to treat and prevent the growth and spread of prostate tumors
US20020183628A1 (en) * 2001-06-05 2002-12-05 Sanford Reich Pressure sensing endograft
US6610096B2 (en) * 2001-08-22 2003-08-26 Macdonald Stuart G. Prosthetic implants having enhanced utility
US6699186B1 (en) * 2000-03-10 2004-03-02 Remon Medical Technologies Ltd Methods and apparatus for deploying and implantable biosensor
US6702847B2 (en) * 2001-06-29 2004-03-09 Scimed Life Systems, Inc. Endoluminal device with indicator member for remote detection of endoleaks and/or changes in device morphology
US6764446B2 (en) * 2000-10-16 2004-07-20 Remon Medical Technologies Ltd Implantable pressure sensors and methods for making and using them
US6805667B2 (en) * 2000-02-04 2004-10-19 Medtronic, Inc. Information remote monitor (IRM) medical device
US6840956B1 (en) * 2000-03-10 2005-01-11 Remon Medical Technologies Ltd Systems and methods for deploying a biosensor with a stent graft
US20050171512A1 (en) * 2000-09-08 2005-08-04 Insulet Corporation Devices, systems and methods for patient infusion
US7025778B2 (en) * 2002-06-07 2006-04-11 Endovascular Technologies, Inc. Endovascular graft with pressure, temperature, flow and voltage sensors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR77132B (en) 1982-03-25 1984-09-07 Coats Ltd J & P
EP0149693B1 (en) * 1984-01-20 1988-06-29 Dräger Nederland B.V. Method of forming an antithrombogenic layer on medical devices
US5578071A (en) 1990-06-11 1996-11-26 Parodi; Juan C. Aortic graft
US6585763B1 (en) 1997-10-14 2003-07-01 Vascusense, Inc. Implantable therapeutic device and method
US6331163B1 (en) * 1998-01-08 2001-12-18 Microsense Cardiovascular Systems (1196) Ltd. Protective coating for bodily sensor
US20020188207A1 (en) * 1998-01-08 2002-12-12 Jacob Richter Anchor for sensor implanted in a bodily lumen
WO2000032092A1 (en) 1998-11-25 2000-06-08 Ball Semiconductor, Inc. Intraluminal monitoring system
US6277078B1 (en) 1999-11-19 2001-08-21 Remon Medical Technologies, Ltd. System and method for monitoring a parameter associated with the performance of a heart
NL1014566C2 (en) 2000-03-06 2001-10-04 Beleggings En Exploitatie Mij Implantable pressure monitoring device.
US6616624B1 (en) * 2000-10-30 2003-09-09 Cvrx, Inc. Systems and method for controlling renovascular perfusion
US7261733B1 (en) 2002-06-07 2007-08-28 Endovascular Technologies, Inc. Endovascular graft with sensors design and attachment methods

Patent Citations (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2634721A (en) * 1951-05-19 1953-04-14 Gen Precision Lab Inc Pressure transducer
US3240207A (en) * 1963-05-31 1966-03-15 North American Aviation Inc Pressure sensor
US3888708A (en) * 1972-02-17 1975-06-10 Kensall D Wise Method for forming regions of predetermined thickness in silicon
US4732874A (en) * 1986-10-15 1988-03-22 Delco Electronics Corporation Removing metal precipitates from semiconductor devices
US4946562A (en) * 1987-01-29 1990-08-07 Medtest Systems, Inc. Apparatus and methods for sensing fluid components
US5013396A (en) * 1987-06-01 1991-05-07 The Regents Of The University Of Michigan Method of making an ultraminiature pressure sensor
US4815472A (en) * 1987-06-01 1989-03-28 The Regents Of The University Of Michigan Multipoint pressure-sensing catheter system
US4881410A (en) * 1987-06-01 1989-11-21 The Regents Of The University Of Michigan Ultraminiature pressure sensor and method of making same
US5207103A (en) * 1987-06-01 1993-05-04 Wise Kensall D Ultraminiature single-crystal sensor with movable member
US5113868A (en) * 1987-06-01 1992-05-19 The Regents Of The University Of Michigan Ultraminiature pressure sensor with addressable read-out circuit
US4834101A (en) * 1987-06-26 1989-05-30 The University Of Michigan Catheter-type electrochemical sensors
US5343064A (en) * 1988-03-18 1994-08-30 Spangler Leland J Fully integrated single-crystal silicon-on-insulator process, sensors and circuits
US4846191A (en) * 1988-05-27 1989-07-11 Data Sciences, Inc. Device for chronic measurement of internal body pressure
US5000049A (en) * 1988-08-02 1991-03-19 Cooper Robert P Pressure gauge for medical applications
US5055838A (en) * 1988-12-09 1991-10-08 The Regents Of The University Of Michigan Silicon tactile imaging array and method of making same
US4953387A (en) * 1989-07-31 1990-09-04 The Regents Of The University Of Michigan Ultrathin-film gas detector
US5165407A (en) * 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor
US5314458A (en) * 1990-06-01 1994-05-24 University Of Michigan Single channel microstimulator
US5213999A (en) * 1990-09-04 1993-05-25 Delco Electronics Corporation Method of metal filled trench buried contacts
US5100479A (en) * 1990-09-21 1992-03-31 The Board Of Regents Acting For And On Behalf Of The University Of Michigan Thermopile infrared detector with semiconductor supporting rim
US5059543A (en) * 1990-09-21 1991-10-22 The Board Of Regents Acting For And On Behalf Of The University Of Michigan Method of manufacturing thermopile infrared detector
US5250461A (en) * 1991-05-17 1993-10-05 Delco Electronics Corporation Method for dielectrically isolating integrated circuits using doped oxide sidewalls
US5250837A (en) * 1991-05-17 1993-10-05 Delco Electronics Corporation Method for dielectrically isolating integrated circuits using doped oxide sidewalls
US5262127A (en) * 1992-02-12 1993-11-16 The Regents Of The University Of Michigan Solid state chemical micro-reservoirs
US5385709A (en) * 1992-02-12 1995-01-31 The Regents Of The University Of Michigan Solid state chemical micro-reservoirs
US5296255A (en) * 1992-02-14 1994-03-22 The Regents Of The University Of Michigan In-situ monitoring, and growth of thin films by means of selected area CVD
US5377524A (en) * 1992-06-22 1995-01-03 The Regents Of The University Of Michigan Self-testing capacitive pressure transducer and method
US5411551A (en) * 1992-08-05 1995-05-02 Ultrasonic Sensing And Monitoring Systems, Inc. Stent assembly with sensor
US5427975A (en) * 1993-05-10 1995-06-27 Delco Electronics Corporation Method of micromachining an integrated sensor on the surface of a silicon wafer
US5531121A (en) * 1993-05-10 1996-07-02 Delco Electronics Corporation Micromachined integrated pressure sensor with oxide polysilicon cavity sealing
US5567989A (en) * 1993-07-27 1996-10-22 Samsung Electronics Co., Ltd. Highly integrated semiconductor wiring structure
US5417235A (en) * 1993-07-28 1995-05-23 Regents Of The University Of Michigan Integrated microvalve structures with monolithic microflow controller
US5756900A (en) * 1993-12-28 1998-05-26 Tasco Japan Co., Ltd. Pressure sensing apparatus
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5653743A (en) * 1994-09-09 1997-08-05 Martin; Eric C. Hypogastric artery bifurcation graft and method of implantation
US5719069A (en) * 1994-09-14 1998-02-17 Delco Electronics Corporation One-chip integrated sensor process
US5547093A (en) * 1994-09-14 1996-08-20 Delco Electronics Corporation Method for forming a micromachine motion sensor
US5598847A (en) * 1994-12-28 1997-02-04 Pacesetter, Inc. Implantable flow sensor apparatus and method
US5676696A (en) * 1995-02-24 1997-10-14 Intervascular, Inc. Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5683449A (en) * 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5989445A (en) * 1995-06-09 1999-11-23 The Regents Of The University Of Michigan Microchannel system for fluid delivery
US5992769A (en) * 1995-06-09 1999-11-30 The Regents Of The University Of Michigan Microchannel system for fluid delivery
US5663508A (en) * 1995-08-07 1997-09-02 Delco Electronics Corporation Silicon flow sensor
US5704352A (en) * 1995-11-22 1998-01-06 Tremblay; Gerald F. Implantable passive bio-sensor
US6140144A (en) * 1996-08-08 2000-10-31 Integrated Sensing Systems, Inc. Method for packaging microsensors
US6136212A (en) * 1996-08-12 2000-10-24 The Regents Of The University Of Michigan Polymer-based micromachining for microfluidic devices
US5706565A (en) * 1996-09-03 1998-01-13 Delco Electronics Corporation Method for making an all-silicon capacitive pressure sensor
US5735887A (en) * 1996-12-10 1998-04-07 Exonix Corporation Closed-loop, RF-coupled implanted medical device
US6053873A (en) * 1997-01-03 2000-04-25 Biosense, Inc. Pressure-sensing stent
US5831162A (en) * 1997-01-21 1998-11-03 Delco Electronics Corporation Silicon micromachined motion sensor and method of making
US6015387A (en) * 1997-03-20 2000-01-18 Medivas, Llc Implantation devices for monitoring and regulating blood flow
US6169321B1 (en) * 1997-06-13 2001-01-02 The Regents Of The University Of Michigan Method and system for locally annealing a microstructure formed on a substrate and device formed thereby
US5976994A (en) * 1997-06-13 1999-11-02 Regents Of The University Of Michigan Method and system for locally annealing a microstructure formed on a substrate and device formed thereby
US6159156A (en) * 1997-08-15 2000-12-12 Rijksuniversiteit Leiden Pressure sensor for use in an artery
US5936164A (en) * 1997-08-27 1999-08-10 Delco Electronics Corporation All-silicon capacitive pressure sensor
US6286369B1 (en) * 1997-09-08 2001-09-11 The Regents Of The University Of Michigan Single-side microelectromechanical capacitive acclerometer and method of making same
US6167757B1 (en) * 1997-09-08 2001-01-02 The Regents Of The University Of Michigan Single-side microelectromechanical capacitive accelerometer and method of making same
US6035714A (en) * 1997-09-08 2000-03-14 The Regents Of The University Of Michigan Microelectromechanical capacitive accelerometer and method of making same
US5915281A (en) * 1997-10-03 1999-06-22 Delco Electronics Corporation Silicon force and displacement sensor
US5967989A (en) * 1997-10-14 1999-10-19 Vascusense, Inc. Ultrasonic sensors for monitoring the condition of a vascular graft
US5807258A (en) * 1997-10-14 1998-09-15 Cimochowski; George E. Ultrasonic sensors for monitoring the condition of a vascular graft
US6231516B1 (en) * 1997-10-14 2001-05-15 Vacusense, Inc. Endoluminal implant with therapeutic and diagnostic capability
US5967986A (en) * 1997-11-25 1999-10-19 Vascusense, Inc. Endoluminal implant with fluid flow sensing capability
US20010026111A1 (en) * 1997-12-30 2001-10-04 Remon Medical Technologies Ltd. Acoustic biosensor for monitoring physiological conditions in a body implantation site
US6237398B1 (en) * 1997-12-30 2001-05-29 Remon Medical Technologies, Ltd. System and method for monitoring pressure, flow and constriction parameters of plumbing and blood vessels
US6239724B1 (en) * 1997-12-30 2001-05-29 Remon Medical Technologies, Ltd. System and method for telemetrically providing intrabody spatial position
US6475170B1 (en) * 1997-12-30 2002-11-05 Remon Medical Technologies Ltd Acoustic biosensor for monitoring physiological conditions in a body implantation site
US6198965B1 (en) * 1997-12-30 2001-03-06 Remon Medical Technologies, Ltd. Acoustic telemetry system and method for monitoring a rejection reaction of a transplanted organ
US6140740A (en) * 1997-12-30 2000-10-31 Remon Medical Technologies, Ltd. Piezoelectric transducer
US6486588B2 (en) * 1997-12-30 2002-11-26 Remon Medical Technologies Ltd Acoustic biosensor for monitoring physiological conditions in a body implantation site
US5932809A (en) * 1998-02-17 1999-08-03 Delco Electronics Corporation Sensor with silicon strain gage
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6062461A (en) * 1998-06-03 2000-05-16 Delphi Technologies, Inc. Process for bonding micromachined wafers using solder
US6109113A (en) * 1998-06-11 2000-08-29 Delco Electronics Corp. Silicon micromachined capacitive pressure sensor and method of manufacture
US5929497A (en) * 1998-06-11 1999-07-27 Delco Electronics Corporation Batch processed multi-lead vacuum packaging for integrated sensors and circuits
US6022756A (en) * 1998-07-31 2000-02-08 Delco Electronics Corp. Metal diaphragm sensor with polysilicon sensing elements and methods therefor
US6232150B1 (en) * 1998-12-03 2001-05-15 The Regents Of The University Of Michigan Process for making microstructures and microstructures made thereby
US6077298A (en) * 1999-02-20 2000-06-20 Tu; Lily Chen Expandable/retractable stent and methods thereof
US6092530A (en) * 1999-03-24 2000-07-25 The B.F. Goodrich Company Remotely interrogated implant device with sensor for detecting accretion of biological matter
US6170488B1 (en) * 1999-03-24 2001-01-09 The B. F. Goodrich Company Acoustic-based remotely interrogated diagnostic implant device and system
US6206835B1 (en) * 1999-03-24 2001-03-27 The B. F. Goodrich Company Remotely interrogated diagnostic implant device with electrically passive sensor
US6171253B1 (en) * 1999-05-04 2001-01-09 Apex Medical, Inc. Flat tube pressure sensor
US6300632B1 (en) * 1999-10-14 2001-10-09 The Regents Of The University Of Michigan Uncooled infrared focal plane imager and microelectromechanical infrared detector for use therein
US6805667B2 (en) * 2000-02-04 2004-10-19 Medtronic, Inc. Information remote monitor (IRM) medical device
US6416474B1 (en) * 2000-03-10 2002-07-09 Ramon Medical Technologies Ltd. Systems and methods for deploying a biosensor in conjunction with a prosthesis
US6840956B1 (en) * 2000-03-10 2005-01-11 Remon Medical Technologies Ltd Systems and methods for deploying a biosensor with a stent graft
US6699186B1 (en) * 2000-03-10 2004-03-02 Remon Medical Technologies Ltd Methods and apparatus for deploying and implantable biosensor
US20020128546A1 (en) * 2000-05-15 2002-09-12 Silver James H. Implantable sensor
US6442413B1 (en) * 2000-05-15 2002-08-27 James H. Silver Implantable sensor
US6477426B1 (en) * 2000-06-20 2002-11-05 Celsion Corporation System and method for heating the prostate gland to treat and prevent the growth and spread of prostate tumors
US20050171512A1 (en) * 2000-09-08 2005-08-04 Insulet Corporation Devices, systems and methods for patient infusion
US6764446B2 (en) * 2000-10-16 2004-07-20 Remon Medical Technologies Ltd Implantable pressure sensors and methods for making and using them
US20020147405A1 (en) * 2001-04-05 2002-10-10 Stephen Denker Cardiac monitoring system and method with multiple implanted transponders
US20020183628A1 (en) * 2001-06-05 2002-12-05 Sanford Reich Pressure sensing endograft
US6702847B2 (en) * 2001-06-29 2004-03-09 Scimed Life Systems, Inc. Endoluminal device with indicator member for remote detection of endoleaks and/or changes in device morphology
US6610096B2 (en) * 2001-08-22 2003-08-26 Macdonald Stuart G. Prosthetic implants having enhanced utility
US7025778B2 (en) * 2002-06-07 2006-04-11 Endovascular Technologies, Inc. Endovascular graft with pressure, temperature, flow and voltage sensors

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060265043A1 (en) * 2002-09-30 2006-11-23 Evgenia Mandrusov Method and apparatus for treating vulnerable plaque
US20080125851A1 (en) * 2002-09-30 2008-05-29 Deborah Kilpatrick Method and apparatus for treating vulnerable plaque
US8613764B2 (en) 2002-09-30 2013-12-24 Abbott Cardiovascular Systems Inc. Method and apparatus for treating vulnerable plaque
US8652194B1 (en) 2002-09-30 2014-02-18 Abbott Cardiovascular Systems Inc. Method and apparatus for treating vulnerable plaque
US8165663B2 (en) 2007-10-03 2012-04-24 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation
US8285366B2 (en) 2007-10-04 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a local bypass
US8285367B2 (en) 2007-10-05 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a reservoir
US20090247887A1 (en) * 2008-03-28 2009-10-01 David Hull Flow measurement in grafts
US8602983B2 (en) 2010-12-20 2013-12-10 Covidien Lp Access assembly having undercut structure
US8641610B2 (en) 2010-12-20 2014-02-04 Covidien Lp Access assembly with translating lumens
US9307974B2 (en) 2010-12-20 2016-04-12 Covidien Lp Access assembly having undercut structure
US8827901B2 (en) 2010-12-20 2014-09-09 Covidien Lp Access assembly with translating lumens
US9277907B2 (en) 2010-12-21 2016-03-08 Covidien Lp Access assembly including inflatable seal member
US8696557B2 (en) 2010-12-21 2014-04-15 Covidien Lp Access assembly including inflatable seal member
US9649113B2 (en) 2011-04-27 2017-05-16 Covidien Lp Device for monitoring physiological parameters in vivo
US11160512B2 (en) 2011-04-27 2021-11-02 Covidien Lp Device for monitoring physiological parameters in vivo
US9314584B1 (en) 2011-06-27 2016-04-19 Bayer Healthcare Llc Method and apparatus for fractional flow reserve measurements
US9615755B2 (en) 2011-06-27 2017-04-11 Bayer Healthcare Llc Method and apparatus for fractional flow reserve measurements
US9757591B2 (en) 2013-02-11 2017-09-12 Bayer Healthcare Llc Methods and systems for monitoring an automated infusion system
US10420583B2 (en) 2013-05-22 2019-09-24 Covidien Lp Methods and apparatus for controlling surgical instruments using a port assembly
US11172958B2 (en) 2013-05-22 2021-11-16 Covidien Lp Methods and apparatus for controlling surgical instruments using a port assembly
US20160220125A1 (en) * 2015-01-30 2016-08-04 Infineon Technologies Ag Implantable Vessel Fluid Sensor
US10433736B2 (en) * 2015-01-30 2019-10-08 Infineon Technologies Ag Implantable vessel fluid sensor
US11883028B2 (en) 2021-09-08 2024-01-30 Covidien Lp Systems and methods for post-operative anastomotic leak detection

Also Published As

Publication number Publication date
EP1511443A1 (en) 2005-03-09
US7261733B1 (en) 2007-08-28
EP1511443B1 (en) 2012-08-01
EP1511443A4 (en) 2009-07-08
WO2003103539A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
US7261733B1 (en) Endovascular graft with sensors design and attachment methods
US7399313B2 (en) Endovascular graft with separable sensors
US7025778B2 (en) Endovascular graft with pressure, temperature, flow and voltage sensors
EP1742594B1 (en) Attachment method of an endovascular graft and a pressor
US20230284975A1 (en) Method and apparatus for measuring flow through a lumen
US6890303B2 (en) Implantable device for monitoring aneurysm sac parameters
US6743180B1 (en) Pressure sensor for use in an artery
US6669647B2 (en) Sensing device and method for determining aneurysmal pressure in a body cavity
US9924905B2 (en) Sensor position on a prosthesis for detection of a stenosis
US20140276136A1 (en) Perioperative feedback in endovascular aneurysm repair using physiological measurements
WO2002000118A2 (en) Pressure gradient measurement for detection of shunt stenosis
JP2024011757A (en) Stent grafts and medical systems
CN116725497A (en) Intravascular pressure gradient determination method
Dawson et al. Pressure Sensor Use with Endovascular Aneurysm Repair

Legal Events

Date Code Title Description
AS Assignment

Owner name: ACACIA RESEARCH GROUP LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ENDOVASCULAR TECHNOLOGIES, INC.;REEL/FRAME:030694/0556

Effective date: 20121220

AS Assignment

Owner name: LIFESHIELD SCIENCES LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACACIA RESEARCH GROUP LLC;REEL/FRAME:030740/0225

Effective date: 20130515

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION